Chemotherapy Remains Significant for Cancer Treatment

Cancer treatment has seen new advances in options such as targeted therapy and immunotherapy, especially when dealing with solid tumors. A recent presentation sparked debate as to whether chemotherapy will continue to be a significant option in the treatment of solid tumor cancers considering the patent centric modalities of therapy.

Although chemotherapy comes with adverse side effects, researchers still think it cannot be excluded from cancer treatment. This follows facts from researches conducted on breast cancer patients since it is prevalent both in incidence and treatment. The disease is often used as a paradigm for research on solid tumors, and it has more non-chemotherapy MOA drugs than other cancers.

According to recent research on the role of chemotherapy in the management of solid tumors in breast cancer:

 Chemotherapy will continue to be used in oncology, whether as a first-line treatment or in combination with other novel MOA drugs. It will continue to be a critical component in cancer treatment for many years to come.

 Advances have also been made to reduce the toxicity of chemotherapy by improving supportive care or limiting exposure through genetic profiling.

 More research is needed to modify or develop new molecules to improve patient experience and outcomes through reduced toxicity and favorable administration of chemotherapy.

 There is also the need for research in the future to re-evaluate the current novel drugs for effectiveness in treating cancer.

Despite all the breakthroughs in cancer therapy and the groundbreaking advances, it is essential to note that they work effectively in targeted populations. At the same time, chemotherapy is vital in various treatment options.

There is hope that research will be conducted to make chemotherapy better, patient-friendly, safer, and more effective.